atai Life Sciences (ATAI) Misses Q2 EPS by 20c
atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.36), $0.20 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $270 thousand.
For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.
